Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Enoblituzumab [USAN]
RN: 1353485-38-7
UNII: M6030H73N9

Molecular Formula

  • C6474-H9990-N1726-O2030-S42 (peptide)
 

Classification Code

  • Treatment of Cancer
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Name of Substance

  • Enoblituzumab [USAN]

Synonyms

  • Enoblituzumab
  • Immunoglobulin G1-kappa, anti-(human CD276 antigen (4Ig-B7-H3, costimulatory molecule)); humanized mouse monoclonal antibody: gamma1 heavy chain (1-452) (human VH (IGHV3-48*02-(IGHD)-IGHJ4*01) (92%) (8.8.15) (1-122) -IGHG1*03 CH2(L5>V (240),R62>P (297)),CH3(P54>L (401)) (123-452) (225-214')-disulfide with kappa light chain (1'-214') (human V-KAPPA (IGKV1D-13*01-IGKJ2*02) (85%) (6.3.9) (1'-107') -IGKC*01 (108'-214')) dimer (231-231'':234-234'')-bisdisulfide
  • MGA271
  • UNII-M6030H73N9

Systematic Name

  • Immunoglobulin G1, anti-(antigen B7-H3) (human-Mus musculus monoclonal MGA271 heavy chain), disulfide with human-Mus musculus monoclonal MGA271 kappa-chain, dimer

Registry Numbers

CAS Registry Number

  • 1353485-38-7

FDA UNII

  • M6030H73N9

System Generated Number

  • 1353485387